Influence of combined use of nicotinamide and carbogen on rat spinal cord radiation tolerance
- 1 May 1994
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 31 (2) , 123-128
- https://doi.org/10.1016/0167-8140(94)90392-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapyRadiotherapy and Oncology, 1993
- Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivoBritish Journal of Cancer, 1991
- The potentiation of radiation damage by nicotinamide in the SCCVII tumour in vivoRadiotherapy and Oncology, 1990
- Radiosensitization by nicotinamide in tumors and normal tissues: The importance of tissue oxygenation statusInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Mechanism of action of the selective tumor radiosensitizer nicotinamideInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Is the rate of repair of radiation-induced sublethal damage in rat spinal cord dependent on the size of dose per fraction?International Journal of Radiation Oncology*Biology*Physics, 1987
- Radiation Damage Repair Capacity of A Human Germ-cell Tumour Cell Line: Inhibition by 3-aminobenzamideInternational Journal of Radiation Biology and Related Studies in Physics, Chemistry and Medicine, 1987
- Hemoglobin, radiation, morbidity and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Inhalation anesthesia in experimental radiotherapy: A reliable and time-saving system for multifractionation studies in a clinical departmentInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiation myelopathy in relation to oxygen levelThe British Journal of Radiology, 1971